Pfizer Advances Duchenne Drug As It Prioritizes Gene Therapy
High value deal with Bamboo Therapeutics starts to come to fruition with start of small study in Duchenne muscular dystrophy, which aims at underlying cause as opposed to symptoms of disease.
